CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 105,693,000 | 102,871,000 | 98,915,000 | 94,588,000 | 97,710,000 |
| Cost of Goods | 59,060,000 | 57,045,000 | 54,005,000 | 51,057,000 | 55,268,000 |
| Gross Profit | 46,633,000 | 45,826,000 | 44,910,000 | 43,531,000 | 42,442,000 |
| Operating Expenses | 44,521,000 | 49,033,000 | 42,529,000 | 40,157,000 | 40,074,000 |
| Operating Income | 2,112,000 | -3,207,000 | 2,381,000 | 3,374,000 | 2,368,000 |
| Interest Expense | 787,000 | 784,000 | 763,000 | 785,000 | 758,000 |
| Other Income | 29,000 | 509,000 | 29,000 | 28,000 | 516,000 |
| Pre-tax Income | 1,354,000 | -3,482,000 | 1,647,000 | 2,617,000 | 2,126,000 |
| Income Tax | -1,569,000 | 508,000 | 634,000 | 835,000 | 503,000 |
| Net Income Continuous | 2,923,000 | -3,990,000 | 1,013,000 | 1,782,000 | 1,623,000 |
| Minority Interests | -20,000 | -15,000 | -8,000 | 3,000 | -21,000 |
| Net Income | $2,943,000 | $-3,975,000 | $1,021,000 | $1,779,000 | $1,644,000 |
| EPS Basic Total Ops | 2.31 | -3.13 | 0.81 | 1.41 | 1.31 |
| EPS Basic Continuous Ops | 2.29 | -3.14 | 0.80 | 1.41 | 1.29 |
| EPS Diluted Total Ops | 2.31 | -3.13 | 0.80 | 1.41 | 1.30 |
| EPS Diluted Continuous Ops | 2.30 | -3.14 | 0.80 | 1.41 | 1.29 |
| EPS Diluted Before Non-Recurring Items | 1.09 | 1.60 | 1.81 | 2.25 | 1.19 |
| EBITDA(a) | $3,259,000 | $3,652,000 | $3,552,000 | $4,528,000 | $3,515,000 |